In particular, the existence of aptamer made the nanoparticles the ability to actively target the overexpressed transferrin receptor (CD71) in pancreatic cancer tissue, thereby enabling a large amount of sonosensitizers to accumulate in the tumor site and amplifying the treatment of orthotopic pancreatic cancer. The gene discussed is TFRC; the disease is familial pancreatic carcinoma.